High-Resolution Anoscopy Global Market Report 2024

The global high-resolution anoscopy market has grown strongly in recent years. It will grow from $13.97 billion in 2023 to $15.03 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increased prevalence of anal dysplasia, advancements in endoscopy technology, growing awareness and screening, colorectal cancer screening.

The global high-resolution anoscopy market is expected to see strong growth in the next few years. It will grow to $19.38 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to global health initiatives, expanded access to specialized care, personalized medicine, telemedicine and remote consultations. Major trends in the forecast period include ai-assisted diagnostics, portable hra devices, digital records and telehealth, home-based hra kits.

The growth of the high-resolution anoscopy market is expected to be significantly propelled by the increasing prevalence of cancer. Cancer represents a diverse group of diseases characterized by the uncontrolled proliferation of abnormal cells. High-resolution anoscopy, utilizing specialized equipment like a colposcope or operating microscope, enables healthcare professionals to obtain precise, high-quality imaging, facilitating detailed assessments of the anal canal. This advanced medical technology plays a crucial role in the identification of cancerous lesions and abnormalities within the anal tract. As evidence, the American Cancer Society's "Cancer Facts and Figures 2023" report reveals an upturn in the number of newly reported anal cancer cases in the United States, reaching 9,760 cases compared to 9,440 cases in 2022. Furthermore, the report indicates an increase in the number of deaths attributed to anal cancer, totaling 1,870, in contrast to the 1,670 recorded in 2022. Hence, the expanding prevalence of cancer is a key driver of the high-resolution anoscopy market's growth.

Anticipated market growth in the high-resolution anoscopy sector is attributed to the increased incidence of sexually transmitted diseases (STDs). Sexually transmitted diseases, also referred to as sexually transmitted infections (STIs), are illnesses transmitted through sexual contact, with causative agents encompassing bacteria, viruses, and parasites. Human papillomavirus (HPV) is responsible for anal dysplasia, necessitating the use of high-resolution anoscopy for diagnostic and therapeutic purposes. The heightened prevalence of STIs contributes to the burgeoning high-resolution anoscopy (HRA) market, serving as a critical tool for early cancer detection and disease management. In fact, data from the World Health Organization, a Switzerland-based specialized agency within the United Nations focusing on global public health, indicates that over 1 million cases of sexually transmitted diseases (STDs) are transmitted globally each day, with a majority of these cases remaining asymptomatic. Thus, the amplified incidence of STDs, which increases the risk of anal cancer, is a primary driver of the high-resolution anoscopy market.

The growth of the high-resolution anoscopy market faces significant challenges due to a lack of awareness and patient reluctance. The procedure involves the use of a colposcope, which is a high-resolution mobile microscope connected to a monitor, for the close examination of suspicious areas in the anal canal through an anoscope. This procedure demands a high level of skill and experience. To address this challenge, manufacturers are actively developing new equipment and techniques to enhance precision and effectiveness in high-resolution anoscopy treatments, with the aim of improving patient acceptance. In a study conducted in 2021, the National Library of Medicine identified a lack of awareness and patient reluctance as potential hindrances to the detection and treatment of anal dysplasia. Consequently, the limited awareness and hesitancy among patients represent significant barriers to the high-resolution anoscopy market's growth.

The high-resolution anoscopy market is witnessing notable advancements driven by the integration of innovative technologies, such as computer-aided cervical mapping technology. Major companies operating in this market are embracing these technologies to enhance the services offered to their clients and maintain their market presence. Computer-aided colposcopy, when combined with cervical mapping, constitutes a cutting-edge device capable of generating valuable data that aids healthcare professionals in the swift detection of cervical abnormalities. For example, in July 2021, DYSIS Medical Inc., a U.S.-based medical technology company specializing in the development of colposcopy devices, introduced the DYSIS View colposcope. This compact and portable colposcope comes equipped with out-of-the-box readiness, making it a convenient solution for healthcare professionals conducting colposcopy examinations. DYSIS View incorporates innovative computer-aided cervical mapping technology, which generates essential data to assist healthcare professionals in the detection and assessment of cervical lesions. It features a high-resolution camera for capturing videos and photos, as well as quick playback of colposcopy tests. Furthermore, it offers DYSIS SMARTtrack for comparing a patient's DYSIS View colposcopy exams and includes a patient database for secure record-keeping.

In December 2022, Olympus, a Japanese company specializing in optical and digital precision technology, completed the acquisition of Odin Vision for an estimated value of $80 million. This strategic acquisition empowers Olympus to integrate Odin's AI solutions into their endoscopy products, providing advanced AI-driven solutions and data-driven insights that have the potential to revolutionize patient care. Odin Vision, based in the UK, is a cloud-AI (artificial intelligence) endoscopy company that aligns with Olympus' vision for innovation in endoscopy and healthcare.

Major players in the high-resolution anoscopy market are Philips Medical Systems Technologies Ltd., Olympus Corporation, Hoya Corporation, Steris PLC, Allegheny Health Network, Karl Storz SE & Co. KG, CooperSurgical, Ecleris S.R.L, Pentax Medical, Fujifilm Medical Systems, Given Imaging, Carl Zeiss Meditec AG, Bovie Medical Corporation, Hill-Rom Holdings Inc., Optomic, Narang Medical Limited, Medorah Meditek Pvt Ltd., Welch Allyn, Leisegang Feinmechanik Optik GmbH, Medimar S.A., DYSIS Medical, Gynius Plus AB, Lutech Medical, Ottomed Endoscopy, Seiler Garepa Pvt. Ltd.

North America was the largest region in the high-resolution anoscopy market in 2023. The regions covered in high-resolution anoscopy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the high-resolution anoscopy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary products associated with high-resolution anoscopy procedures include colposcopes, portable colposcopes, hand-held colposcopes, anoscopes, disposable anoscopes, and reusable anoscopes. Colposcopes are medical devices utilized by gynecologists and other healthcare professionals for detailed examinations of the cervix, vagina, and vulva. These instruments can be used on both adult and pediatric patients and are commonly found in various healthcare settings, including hospitals, diagnostic laboratories, and specialty clinics, for the examination and assessment of anal and gynecological conditions.

This report provides high-resolution anoscopy market statistics, including high-resolution anoscopy industry global market size, regional shares, competitors with a high-resolution anoscopy market share, detailed high-resolution anoscopy market segments, market trends and opportunities and any further data you may need to thrive in the high-resolution anoscopy industry. This high-resolution anoscopy market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The high-resolution anoscopy market consists of revenues earned by entities by providing services such as anal dysplasia screening, acetic acid application and pathology analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The high-resolution anoscopy market also includes sales of beveled anoscopes and slotted or side-opening anoscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.